These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27998714)

  • 1. A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence.
    Barrios V; Escobar C; Cicero AF; Burke D; Fasching P; Banach M; Bruckert E
    Atheroscler Suppl; 2017 Feb; 24():1-15. PubMed ID: 27998714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.
    Marazzi G; Pelliccia F; Campolongo G; Quattrino S; Cacciotti L; Volterrani M; Gaudio C; Rosano G
    Am J Cardiol; 2015 Dec; 116(12):1798-801. PubMed ID: 26611120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
    Marazzi G; Campolongo G; Pelliccia F; Quattrino S; Vitale C; Cacciotti L; Massaro R; Volterrani M; Rosano G
    Am J Cardiol; 2017 Sep; 120(6):893-897. PubMed ID: 28781026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.
    Ruscica M; Gomaraschi M; Mombelli G; Macchi C; Bosisio R; Pazzucconi F; Pavanello C; Calabresi L; Arnoldi A; Sirtori CR; Magni P
    J Clin Lipidol; 2014; 8(1):61-8. PubMed ID: 24528686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q
    D'Addato S; Scandiani L; Mombelli G; Focanti F; Pelacchi F; Salvatori E; Di Loreto G; Comandini A; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():1585-1592. PubMed ID: 28579756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
    Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment.
    Marazzi G; Campolongo G; Pelliccia F; Calabrò Md P; Cacciotti L; Vitale C; Massaro R; Volterrani M; Rosano G
    Am J Cardiol; 2019 Jan; 123(2):233-238. PubMed ID: 30420184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus
    Cicero AFG; Fogacci F; Tocci G; D'Addato S; Grandi E; Banach M; Borghi C
    Arch Med Sci; 2023; 19(5):1169-1179. PubMed ID: 37732047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
    Pirro M; Mannarino MR; Bianconi V; Simental-Mendía LE; Bagaglia F; Mannarino E; Sahebkar A
    Pharmacol Res; 2016 Aug; 110():76-88. PubMed ID: 27157250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
    Sullivan D; Olsson AG; Scott R; Kim JB; Xue A; Gebski V; Wasserman SM; Stein EA
    JAMA; 2012 Dec; 308(23):2497-506. PubMed ID: 23128163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.
    Angelopoulos N; Paparodis RD; Androulakis I; Boniakos A; Argyrakopoulou G; Livadas S
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical Investigation.
    Cicero AFG; Fogacci F; Bove M; Ventura F; Giovannini M; Borghi C
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):355-359. PubMed ID: 30229462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Bempedoic Acid in Dyslipidemia Management.
    Kelly MS; Sulaica EM; Beavers CJ
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):376-388. PubMed ID: 32732494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation.
    Cicero AF; Rovati LC; Setnikar I
    Arzneimittelforschung; 2007; 57(1):26-30. PubMed ID: 17341006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents.
    Ward N; Sahebkar A; Banach M; Watts G
    Curr Opin Lipidol; 2017 Dec; 28(6):495-501. PubMed ID: 28858885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
    Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
    Cicero AFG; Fogacci F; Zambon A
    J Am Coll Cardiol; 2021 Feb; 77(5):620-628. PubMed ID: 33538260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.